# Business Requirements Document (BRD)
# AI-native Drug Discovery Operating System (AI-RxOS)
Version: 1.0
Prepared By: Neozenone AI
Status: Draft

# 1. Executive Summary
The AI-native Drug Discovery Operating System (AI-RxOS) is an enterprise platform that augments the entire drug discovery lifecycle through AI agents, scientific knowledge graphs, foundation models, and automated literature intelligence.
Unlike traditional ELNs (Electronic Lab Notebook), LIMS (Laboratory Information Management System), or AI search tools, AI-RxOS functions as an intelligent research operating system that continuously ingests global biomedical knowledge, reasons over scientific evidence, generates hypotheses, prioritizes therapeutic opportunities, and assists scientists in discovering first-in-class and best-in-class therapeutics.
The platform supports:
- Pharmaceutical companies
- Biotechnology companies
- Academic medical centers
- Venture Capital firms
- Licensing teams
- Business Development organizations

# 2. Vision
Become the operating system powering next-generation therapeutic discovery by combining human scientists with autonomous AI research agents.

# 3. Mission
Reduce drug discovery timelines from years to months by enabling AI-assisted scientific reasoning, automated knowledge synthesis, and intelligent portfolio optimization.

# 4. Business Goals
## Primary Goals
Reduce literature review effort by >90%.
Identify first-in-class opportunities earlier.
Improve target prioritization.
Accelerate IND (Investigational New Drug) candidate selection.
Reduce R&D costs.
Increase licensing success.
Enable AI-assisted due diligence.

# 5. Success Metrics
Time to scientific insight
Time to target nomination
Number of validated hypotheses
Reduction in manual literature review
Portfolio ROI
Prediction accuracy
Scientist productivity
Number of AI-generated hypotheses accepted

# 6. Target Customers
### Tier 1
Large Pharmaceutical Companies
### Tier 2
Clinical-stage Biotechnology Companies
### Tier 3
Drug Discovery Startups
### Tier 4
VC and Investment Firms
### Tier 5
Academic Research Centers

# 7. Platform Overview
The platform consists of eight major modules:
- Scientific Knowledge Graph
- Literature Intelligence
- AI Research Copilot
- Drug Discovery Workspace
- Portfolio Intelligence
- Molecule Discovery
- Clinical Prediction
- Enterprise Administration

# 8. Core Modules
## Module 1 — Scientific Knowledge Graph
Purpose
Create a continuously updated biomedical graph.
Entities
Genes
Proteins
Pathways
Diseases
Drugs
Companies
Clinical Trials
Publications
Patents
Biomarkers
Conferences
Relationships
Drug → Target
Target → Disease
Drug → Trial
Gene → Biomarker
Drug → Patent
Drug → Conference
Drug → Publication

## Module 2 — Literature Intelligence
Automatically ingest
PubMed
bioRxiv
medRxiv
AACR
ASCO
SABCS
ESMO
ClinicalTrials.gov
Patents
Company Press Releases
SEC Filings
Capabilities
Automatic summarization
Entity extraction
Knowledge graph generation
Duplicate detection
Scientific novelty scoring
Evidence ranking
Citation linking

## Module 3 — AI Research Copilot
Capabilities
Natural language querying
Scientific reasoning
Hypothesis generation
Mechanism explanation
Competitive analysis
Target comparison
Portfolio recommendation
Clinical strategy generation
Example
"Find BBB-penetrant HER2 inhibitors in Phase I with improved selectivity over tucatinib."

## Module 4 — Competitive Intelligence
Track
Drug pipelines
Conference presentations
Patents
Company announcements
Clinical trial updates
Funding rounds
Leadership changes
Outputs
Competitor dashboards
Market maps
Technology landscapes
Threat analysis
Licensing opportunities

## Module 5 — Molecule Discovery
Input
Target
Binding pocket
SMILES
Protein structure
Capabilities
Virtual screening
Generative chemistry
Docking
ADMET prediction
BBB prediction
PK prediction
Toxicity prediction
Synthetic accessibility
Output
Ranked candidate molecules

## Module 6 — Portfolio Builder
Evaluate
Scientific novelty
Commercial opportunity
Competition
Patent landscape
Development cost
Probability of success
Output
Portfolio score
Investment recommendation
Priority ranking

## Module 7 — Clinical Prediction
Predict
Probability of Phase I success
Phase II success
Phase III success
Overall approval probability
Potential indications
Companion diagnostics
Combination therapies

## Module 8 — Due Diligence Assistant
Upload
Pitch Deck
Patent
Scientific Paper
Clinical Protocol
Outputs
Scientific review
Competitive landscape
Patent overlap
Strengths
Weaknesses
Investment recommendation
Risk analysis

# 9. AI Agents
Target Discovery Agent
Literature Agent
Conference Agent
Patent Agent
Clinical Trial Agent
Competitive Intelligence Agent
Knowledge Graph Agent
Molecule Discovery Agent
Docking Agent
Medicinal Chemistry Agent
Safety Agent
ADMET Agent
Portfolio Agent
Regulatory Agent
Commercial Strategy Agent
Scientific Writer Agent
Meeting Assistant Agent
Research Coordinator Agent

# 10. User Roles
Research Scientist
Medicinal Chemist
Computational Biologist
Clinical Scientist
Program Manager
Business Development
Licensing Team
Executive Leadership
Investor
Administrator

# 11. Functional Requirements
Authentication (Better Auth Framework)
Role-based access control (Better Auth RBAC Plugin)
Project workspaces
Shared notebooks
Knowledge graph search
Conversational AI
Semantic search (LLM Wiki & Open Knowledge Format)
Scientific dashboards
Versioning
Document management
API integrations
Workflow automation
Notifications
Audit logs
Report generation

# 12. Non-functional Requirements
Availability: 99.9%
Scalability to millions of publications
Sub-second semantic search (qmd Search over OKF Bundle)
Enterprise security
SOC2 readiness
HIPAA-ready architecture
Encryption at rest
Encryption in transit
Horizontal scaling
Full auditability

# 13. Data Sources
PubMed
PubMed Central
ClinicalTrials.gov
ChEMBL
DrugBank
UniProt
PDB
Open Targets
OpenAlex
CrossRef
Google Patents
USPTO
EPO
Company websites
Conference abstracts

# 14. Integrations
OpenAI
NVIDIA BioNeMo
ESM
AlphaFold
Evo2
RDKit
Schrödinger
PyTorch
Nextflow
AWS
Azure
Google Cloud

# 15. AI Models
Biomedical LLM
Scientific RAG (LLM Wiki & OKF v0.1)
Knowledge Graph Embeddings
Graph Neural Networks
Protein Language Models
Molecular Foundation Models
Docking Models
Survival Models
Clinical Prediction Models
Multi-Agent Orchestrator

# 16. Security
Better Auth Authentication Framework
SSO, OIDC & OAuth2 Provider Capabilities
Stateless JWT Local Verification via JWKS
Better Auth Plugins (Organization, Admin/RBAC, API-Key)
ABAC & Attribute-Based Access Control
Project isolation
Encryption
Audit logging
Secret management
Compliance monitoring

# 17. Analytics
Research productivity
Drug pipeline analytics
Portfolio health
Competitor intelligence
Publication trends
Conference trends
Patent analytics
Clinical success metrics

# 18. Future Roadmap
Phase 1
Knowledge Graph
Scientific Search
Research Copilot
Competitive Intelligence
Phase 2
Molecule Discovery
Docking
Generative Chemistry
Portfolio Builder
Phase 3
Autonomous AI Scientists
Laboratory Integration
Closed-loop Learning
Digital Twin Simulations
AI-driven IND Planning

# 19. Commercial Model
Software-as-a-Service
Enterprise Licensing
Usage-based AI Compute
API Platform
Professional Services
Private Cloud Deployments

# 20. Expected Business Outcomes
50–70% reduction in literature review time
3–5× increase in research productivity
Earlier identification of first-in-class opportunities
Improved licensing decisions
Reduced discovery costs
Higher probability of clinical success
Creation of proprietary organizational knowledge
